Robert J. Hariri, M.D., Ph.D.,
Chairperson, Founder, and Chief Executive Officer
Dr. Bob Hariri is an accomplished surgeon, biomedical scientist, and serial entrepreneur in two technology sectors, biomedicine and aerospace.
Dr. Hariri was the founder and CEO of Anthrogenesis Corporation, and after its acquisition by Celgene Corporation, served as CEO of Celgene Cellular Therapeutics. This division then became Celgene’s one and only spin off company late in 2017 forming Celularity
“Part of the motivation for creating Celularity was to create a focal point to pull together intellectual assets, human capital and financial resources so that breakthroughs could be approached with the intensity that is needed…”
Robert J. Hariri, M.D., Ph.D.
Experienced Cellular Medicine Leaders & Innovators
Backed by 100+ years of combined experience, our seasoned team of biopharmaceutical executives, scientists and clinicians have been integral to the success of numerous programs across discovery research, clinical development and commercialization in cancer immunotherapies and cell therapeutics.
The Best Team
- Best-in-class company leveraging 20+ years’ developing innovative cellular medicines and advanced biomaterials
- Proprietary cellular medicine and advanced biomaterials pipelines with expansive freedom to operate
- World-leading manufacturing and translational research center paired with an agile, economically scalable business model
With Deep Expertise in
Clinical Development & Regulatory Approval
We are a deep, seasoned management team with experience in all aspects of cellular medicine, including clinical development, product approval, manufacturing and process development, and commercialization.